Trials / Recruiting
RecruitingNCT05266066
Ventilator-associated Tracheobronchitis Initiative to Conduct Antibiotic Evaluation
Multicenter Randomized Clinical Trial of Antimicrobial Treatment in Ventilator-associated Tracheobronchitis
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 590 (estimated)
- Sponsor
- Hospital Sirio-Libanes · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Ventilator Associated tracheobronchitis Initiative to Conduct Antibiotic evaluation (VATICAN) trial is a national, multicenter, non-inferiority trial in ICU patients comparing antibiotic treatment for 7 days versus clinical observation without antibiotic treatment for patients with ventilator-associated tracheobronchitis.
Detailed description
There is no consensus on the need for antibiotic treatment for ventilator-associated tracheobronchitis (VAT). There's a lack of high-quality clinical data on this subject, and although some observational studies recommend antibiotic treatment for VAT, some guidelines do not. The VATICAN is a prospective, randomized, single-blinded (analysis), non-inferiority trial evaluating antibiotic treatment for patients with ventilator-associated tracheobronchitis. Patients with clinically diagnosed tracheobronchitis will be randomized to receive antibiotics for 7 days versus clinical observation without antibiotic treatment for VAT. The primary hypothesis is that clinical observation without antibiotic treatment is noninferior to 7-day antibiotic course.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Clinical observation without antibiotic therapy for VAT | Patients will receive standard care plus antibiotic if new organ dysfunction or new infections other than VAT. |
| OTHER | 7 day antibiotic course for VAT | Patients will receive standard care plus 7 day course of antibiotic. |
Timeline
- Start date
- 2022-07-11
- Primary completion
- 2026-11-01
- Completion
- 2026-12-01
- First posted
- 2022-03-04
- Last updated
- 2025-06-19
Locations
16 sites across 1 country: Brazil
Source: ClinicalTrials.gov record NCT05266066. Inclusion in this directory is not an endorsement.